Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
- PMID: 24590984
- DOI: 10.1002/hep.27060
Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
Abstract
Acetaminophen (APAP) overdose is a leading cause of drug-induced hepatotoxicity and acute liver failure worldwide, but its pathophysiology remains incompletely understood. Fibroblast growth factor 21 (FGF21) is a hepatocyte-secreted hormone with pleiotropic effects on glucose and lipid metabolism. This study aimed to investigate the pathophysiological role of FGF21 in APAP-induced hepatotoxicity in mice. In response to APAP overdose, both hepatic expression and circulating levels of FGF21 in mice were dramatically increased as early as 3 hours, prior to elevations of the liver injury markers alanine aminotransferase (ALT) and aspartate aminotransferase (AST). APAP overdose-induced liver damage and mortality in FGF21 knockout (KO) mice were markedly aggravated, which was accompanied by increased oxidative stress and impaired antioxidant capacities as compared to wild-type (WT) littermates. By contrast, replenishment of recombinant FGF21 largely reversed APAP-induced hepatic oxidative stress and liver injury in FGF21 KO mice. Mechanistically, FGF21 induced hepatic expression of peroxisome proliferator-activated receptor coactivator protein-1α (PGC-1α), thereby increasing the nuclear abundance of nuclear factor erythroid 2-related factor 2 (Nrf2) and subsequent up-regulation of several antioxidant genes. The beneficial effects of recombinant FGF21 on up-regulation of Nrf2 and antioxidant genes and alleviation of APAP-induced oxidative stress and liver injury were largely abolished by adenovirus-mediated knockdown of hepatic PGC-1α expression, whereas overexpression of PGC-1α was sufficient to counteract the increased susceptibility of FGF21 KO mice to APAP-induced hepatotoxicity.
Conclusion: The marked elevation of FGF21 by APAP overdose may represent a compensatory mechanism to protect against the drug-induced hepatotoxicity, by enhancing PGC-1α/Nrf2-mediated antioxidant capacity in the liver.
© 2014 by the American Association for the Study of Liver Diseases.
Comment in
-
Fibroblast growth factor 21: a new liver safeguard.Hepatology. 2014 Sep;60(3):792-4. doi: 10.1002/hep.27147. Epub 2014 May 9. Hepatology. 2014. PMID: 24668840 No abstract available.
Similar articles
-
FGF21 mediates the protective effect of fenofibrate against acetaminophen -induced hepatotoxicity via activating autophagy in mice.Biochem Biophys Res Commun. 2018 Sep 5;503(2):474-481. doi: 10.1016/j.bbrc.2018.04.157. Epub 2018 Jul 10. Biochem Biophys Res Commun. 2018. PMID: 29730296
-
Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice.J Hepatol. 2014 Oct;61(4):825-31. doi: 10.1016/j.jhep.2014.05.033. Epub 2014 Jun 2. J Hepatol. 2014. PMID: 24882054
-
Reversal of bioenergetics dysfunction by diphenyl diselenide is critical to protection against the acetaminophen-induced acute liver failure.Life Sci. 2017 Jul 1;180:42-50. doi: 10.1016/j.lfs.2017.05.012. Epub 2017 May 10. Life Sci. 2017. PMID: 28501483
-
Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.Dig Dis. 2015;33(4):464-71. doi: 10.1159/000374090. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159260 Free PMC article. Review.
-
Autophagy and acetaminophen-induced hepatotoxicity.Arch Toxicol. 2018 Jul;92(7):2153-2161. doi: 10.1007/s00204-018-2237-5. Epub 2018 Jun 6. Arch Toxicol. 2018. PMID: 29876591 Review.
Cited by
-
Mitochondrial Damage and Biogenesis in Acetaminophen-induced Liver Injury.Liver Res. 2019 Dec;3(3-4):150-156. doi: 10.1016/j.livres.2019.10.002. Epub 2019 Nov 1. Liver Res. 2019. PMID: 32655976 Free PMC article.
-
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.J Clin Endocrinol Metab. 2019 Aug 1;104(8):3327-3336. doi: 10.1210/jc.2018-02414. J Clin Endocrinol Metab. 2019. PMID: 30848827 Free PMC article.
-
FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity.Autophagy. 2024 Mar;20(3):489-504. doi: 10.1080/15548627.2023.2259282. Epub 2023 Sep 24. Autophagy. 2024. PMID: 37722816 Free PMC article.
-
Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?Skelet Muscle. 2023 Aug 4;13(1):12. doi: 10.1186/s13395-023-00320-4. Skelet Muscle. 2023. PMID: 37537627 Free PMC article.
-
Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus.Theranostics. 2020 Feb 3;10(6):2675-2695. doi: 10.7150/thno.40735. eCollection 2020. Theranostics. 2020. PMID: 32194828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials